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Abstract
We sought to investigate the risk of incident major depressive disorder (MDD) attributable to a range of sleep disorders in the Danish population.
Datawere obtained by linking longitudinalDanish population-based registers. A total of 65,739 individualswhohad first onset of depression between
1995 and 2013were selected as cases. For each case, a set of 20 controls of the same sex, birthmonth and year andwho had not had depression by the
date that the case was diagnosedwere selected at random form the population (N= 1,307,580 in total).We examinedwhether there was an increased
rate of prior sleep disorders inMDDcases compared to controls using conditional logistic regression.An increased risk of incident depression in cases
was found for all sleep disorders analyzed. Highest incidence rate ratios (IRRs) were found for circadian rhythm disorders (IRR= 7.06 [2.78–17.91])
and insomnia of inorganic origin (IRR= 6.76 [4.37–10.46]). The lowest estimated IRRwas for narcolepsy (IRR= 2.00 [1.26–3.17]). Those diagnosed
with a sleep disorder in the last 6months were at highest risk of developing depression compared to those with at least 1 year since diagnosis (3.10 vs.
2.36). Our results suggest that having any sleep disorder is a risk factor for incident depression. Depression screening should be considered for
patients with sleep disorders, and where possible, long-term follow-up for mental health problems is advisable.
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Difficulties with sleep and disruptions to circadian rhythms are
hallmarks of psychiatric disorders. In the case of mood disorders,
disruptions to sleep can form part of a clinical diagnosis based on
the criteria established in the Diagnostic and Statistical Manual of
Mental Disorders (5th ed., DMS-V, American Psychiatric
Association, 2013). Both insomnia and hypersomnia can form part
of a diagnosis of major depressive disorder (MDD), the most
common mood disorder (Pedersen et al., 2014). Sleep and mood
are tightly linked, with mood tending to decrease as time since last
sleep increases, and interventions to improve poor sleep can
improve symptoms of depression (Christensen et al., 2016).
While previously seen as a symptom of MDD, there is increas-
ing recognition that sleeping difficulties can occur prior to onset of
depression and are a risk factor for MDD. A number of seminal
studies have found increased rates of depression among patients
with sleep disorders, including insomnia and hypersomnia
(Breslau et al., 1996; Ford & Kamerow, 1989), narcolepsy
(Ohayon, 2013), obstructive sleep apnea (OSA; Peppard et al.,
2006) and restless leg syndrome (Becker & Sharon, 2014). An
important aspect of treating sleep disorders is understanding the
risks of developing MDD in patients and ensuring that appropriate
treatment is given. Likewise, patients presenting with MDD may
have an underlying sleep disorder that when treated will lead to
remittance of depression symptoms.
For some disorders such as parasomnias and circadian rhythm
disorders, studies showing increased rates of depression in cases
have only been correlational or cross-sectional, since longitudinal
studies are costly. For other disorders such as insomnia, existing
studies that have identified increased risk of depression in patients
have utilized a range of epidemiological designs with different
strengths and weaknesses. In some instances, the associations were
evaluated in cross-sectional studies where the order of the outcome
and exposure are unknown. Other studies have focused on specific
age ranges or have used clinical cohorts that have been heavily
ascertained for sleep disorders and may not be representative of
the general population. Moreover, previous studies of the temporal
relationship between sleep disorders and MDD have been limited
by short follow-up periods where onset of depression has been
assessed at specified intervals, rather than on a continouous basis.
Adjustment for confounding factors such as cohabitation status,
employment and income has also not been possible for the
most part.
The aim of this study was to further our understanding of sleep
disorders as a risk factor for incident depression. Specifically, we
sought to estimate the increased risk of developing MDD in those
with sleep disorders in an entire population. We utilize the Danish
national registers, which contain records on all general and psychi-
atric hospital visits for the entire Danish population.
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Methods
Data
Data were obtained by linking longitudinal Danish population-
based registers using the unique personal identification number
assigned to all people living in Denmark since 1969 (Pedersen
et al., 2006). Socioeconomic and demographic data were obtained
from the Danish Civil Registration System (Pedersen, 2011) and
the Danish Integrated Database for Labour Market Research
(Petersson et al., 2011). Information on sleep disorders was
obtained from the Danish National Hospital Register (Lynge
et al., 2011) and the Danish Psychiatric Central Research
Register (Mors et al., 2011) and major depression diagnoses were
taken only from the latter. The former was established in 1977 and
the latter in 1969. The psychiatric register is based on diagnoses
made by psychiatrists according to the Danish version of the
International Classification of Disease (ICD)-8 and ICD-10 classi-
fication and contains computerized records on all inpatients from
1969 to 1994, and all in- and outpatients from 1994 to 2013
(Munk-Jorgensen & Mortensen, 1997). Likewise, the Danish
National Hospital Register contains computerized records of all in-
patient visits to Danish hospitals since 1977. Health care is pro-
vided free of charge to the patients in Denmark. Diagnoses of
sleep disorders and major depression were only included when
listed as the primary diagnosis.
Until 1994, diagnosis was given according to ICD-8 codes and
from 1995 onwards according to ICD-10 codes. ICD-8 codes do
not provide any information on specific diagnoses of sleep disor-
ders; therefore, the present study includes only information on
sleep disorders from 1995 onwards. Depression diagnosis is
included in the ICD-8, and so data in that period were used to
ensure that cases were not previously treated for depression.
Study Design
We used a nested case–control design (Borgan et al., 1995) to
account for variability in depression and sleep disorder risk across
ages and across time. MDD cases were defined as described in
Laursen et al.’s (2016) first diagnosis of depression in the registers
between 1995 and 2013 (defined as ICD-10 codes F32 and F33 and
no ICD-8 codes 296.09, 296.29, 296.99, 298.09, 300.49 prior to
1995) with first recorded onset of depression between 15 and 60
years. All cases were born in Denmark and living in Denmark
when becoming a case. Cases were also required to have been living
in Denmark from one year before the study period (from 1994) or
from when they were 15 years old, whichever came last. Lastly,
cases were required to not have been diagnosed with a sleep dis-
order on the same day as being diagnosed with depression.
For each case, a set of 20 controls who had not been diagnosed
withMDD by the diagnosis date of the case and who were matched
for gender and birth month and year was selected at random from
the population. Controls were also required to have been living in
Denmark from the year prior to the exposure period (1994
onwards) or from age 15 onwards, whichever came latest.
Individuals who subsequently went on to be diagnosed with
MDD, but who did have a recorded diagnosis of depression on
the day that the case of interest was diagnosed, could be included
as matched controls to previously observed cases.
Sleep disorders from the F and G chapters of the ICD-10 were
included as exposure variables. Disorders from the F chapter are
classified as inorganic sleep disorders — those without a known
physical cause. Disorders in the G chapter are classified as organic
disorders. Supplementary Table 1 shows the ICD-10 codes that
were included and how they were grouped into broad diagnoses
(e.g., insomnia, hypersomnia, parasomnias).
For disorders for which there are both inorganic and organic
forms, we considered both the overall broad diagnoses as well as
the inorganic group and organic group if the sample size was large
enough to estimate the risk ratio within a reasonably sized confi-
dence interval. This was also partly due to privacy issues associated
with the use of the registers for research that restrict analyses to
sample sizes above a set threshold. We further considered all inor-
ganic sleep disorders (all diagnoses with ICD-10 codes F50–59)
and all organic sleep disorders (all diagnoses with ICD-10 codes
G47.0x–G47.6x) together as risk factors. The ICD-10 codes that
were considered and the diagnostic groups into which they fall
are shown in Supplementary Table 1. Not all ICD-10 codes for
sleep disorders were present in the register.
Socioeconomic and demographic variables were extracted for
each individual in the study from the registers. We considered
labour market participation, income, education, cohabiting status
and degree of urbanization of place of residence from the year prior
to depression onset as covariates that were adjusted for in the
analysis. Employment status was divided into those in full employ-
ment, those who were unemployed but seeking work, those on
leave such as family, sick or military leave, those receiving social
benefits and a final group consisting of those outside the workforce
but not seeking work. Income was normalized by year, birth year
and gender, and divided into quintiles. Education was divided into
five domains according to the highest level of education achieved.
Couples who were married, in registered partnerships, or whowere
living together were considered as cohabiting and compared to
those who were single or children living with parents.
Statistical Analysis
The incidence rate ratio (IRR) of MDD associated with sleep dis-
orders was estimated by conditional logistic regression, with each
case considered to be a separate stratum using the PHREG function
in SAS 9.4. Both unadjusted IRRs and IRRs adjusted for marital
status, cohabitation status, annual income (divided into quintiles
by calendar year, age and sex), education level and parental psychi-
atric disorders were estimated. Within groups of disorders, we
evaluated and compared the IRRs for sleep disorders within the
six months prior to depression, disorders with onset between six
months and one year prior to depression, and those occurring
more than one year prior to depression. Odds ratios from a stan-
dard logistic regression of sleep disorders on depression case/con-
trol status are presented for comparison.
Results
A total of 65,379 individuals met the criteria for being a case and
1,307,580 matched controls were included in the analysis.
Supplementary Table 2 provides an overview of the sample char-
acteristics. The sample included 62.7% women, reflecting the
higher incidence of MDD in women in the Danish population
(Pedersen et al., 2014). As expected based on previous studies,
the risk of depression was higher in those with lower incomes,
shorter time in education, those who were unemployed, not mar-
ried and living in large cities (Supplementary Table 2).
The frequency of each group of sleep disorders in cases and con-
trols as well as a selected number of subdiagnoses where there was
sufficient sample size to evaluate risk of depression are provided in
Table 1. Many individual diagnoses did not have enough cases to
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Table 1. Sleep disorders evaluated as risk factors for fepression and their frequency in depression cases and controls
Disorder Subdisorder/group ICD-10 code Cases Controls
Percentage
in cases
Percentage in
Controls
Odds ratio
of MDD
Lower
95% CI
Upper
95% CI
Insomnia All 62 206 0.094 0.016 6.02 4.53 8.00
Inorganic insomnia F51.0x 27 80 0.041 0.006 6.76 4.37 10.45
Paradoxical insomnia F51.03 17 39 0.026 0.003 8.73 4.94 15.42
Organic insomnia G47.0z 18 87 0.027 0.007 4.14 2.49 6.88
Hypersomnia All
Inorganic hypersomnia F51.1x less
than 4
36 N/A N/A
Organic hypersomnia G47.1x 53 380 0.081 0.029 2.79 2.09 3.72
Circadian rhythm sleep
disorders
Nonorganic circadian
rhythm disorder
F51.2x 6 17 0.009 0.001 7.07 2.79 17.92
Parasomnias All 31 222 0.047 0.017 2.79 1.92 4.07
Inorganic parasomnia F51.3–F51.5 19 134 0.029 0.010 2.84 1.76 4.59
Organic parasomnia G47.5x 12 88 0.018 0.007 2.73 1.49 4.99
Sleep-related
movement disorders
All G47.6z 47 298 0.071 0.023 3.16 2.32 4.29
Narcolepsy All G47.4x 20 200 0.030 0.015 2.00 1.26 3.17
SDB All G47.3x 422 3627 0.642 0.276 2.32 2.10 2.57
OSA G47.33 45 245 0.068 0.019 3.68 2.67 5.05
All inorganic sleep
disorders
F51.0–F51.9 73 306 0.111 0.023 4.77 3.70 6.16
All organic disorders G47.0–G47.6 511 4270 0.777 0.325 2.39 2.18 2.62
All sleep disorders F51.0–G47.6 584 4576 0.888 0.348 2.55 2.33 2.78
Table 2. IRRs for depression by sleep disorder classification
Disorder Subdisorder/group IRR Lower 95% CI Upper 95% CI p-value Adjusted IRR Lower 95% CI Upper 95% CI p-value
Insomnia Inorganic 6.76 4.37 10.46 * 5.80 3.67 9.17 *
Organic 4.20 2.53 6.98 * 3.71 2.19 6.28 *
All 5.47 3.92 7.64 * 4.72 3.34 6.69 *
Hypersomnia Organic 2.80 2.10 3.73 * 2.60 1.94 3.49 *
All 2.72 2.06 3.60 * 2.53 1.89 3.36 *
Circadian rhythm disorders Inorganic 7.06 2.78 17.91 * 3.79 1.44 9.95 .007
Parasomnia Inorganic 2.85 1.77 4.60 * 2.72 1.67 4.45 *
Organic 2.40 0.73 7.95 .15 2.33 0.69 7.90 .17
All 2.80 1.79 4.37 * 2.66 1.70 4.22 *
Other inorganic sleep disorders
(not elsewhere classified)
8.72 5.08 14.97 * 6.74 3.82 11.88 *
All inorganic sleep disorders 4.80 3.72 6.19 * 4.09 3.14 5.33 *
Narcolepsy 2.00 1.26 3.17 .003 1.24 0.69 2.26 .47
SDB 2.36 2.13 2.61 * 1.97 1.73 2.24 *
OSA 3.69 2.68 5.08 * 3.58 2.58 4.97 *
Sleep movement disorder 3.15 2.32 4.29 * 2.99 2.18 4.11 *
Any organic sleep disorder 2.47 2.26 2.71 * 2.20 2.01 2.41 *
Any sleep disorder 2.62 2.41 2.86 * 2.33 2.13 2.54 *
Note: *p value < .001.
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permit estimation of IRRs for depression. In many instances, a
general diagnosis code for a disorder was given in the registers.
For example, the code F51.0 was the most frequently used code
for insomnia, rather than the more specific codes for subtypes
of insomnia such as paradoxical insomnia F51.03.
The IRRs for all of the sleep disorders examined are shown in
Table 2. The IRRs were highest for inorganic circadian rhythm dis-
orders (IRR= 7.06, adjusted IRR= 3.61) and inorganic insomnia
(IRR = 6.76, adjusted IRR= 6.16). These results reflect a trend that
inorganic disorders had a higher associated risk of developing
depression than organic disorders (IRR 4.80 compared to 2.47).
The IRRs by sex for disorders with sufficient sample size to cal-
culate them are presented in Supplementary Table 3. The most
notable differences between sexes were for insomnia, where the
IRR across all types of insomnia was 7.29 (4.42–12.03) for men
in the unadjusted model and 4.44 (2.83–6.98) in women, and sleep
movement disorders, where the unadjusted IRR was 4.39 (2.99–
6.44) in women and 1.97 (1.16–3.35) in men, but these differences
are not statistically significant. Across all disorders, the estimated
IRR for women was slightly higher in the unadjusted model— 2.94
(2.55–3.38) compared to 2.47 (2.06–2.74). However, after adjusting
for potential confounders, the estimated IRRs were approximately
the same in both women and men — 2.37 (2.06–2.74) and 2.28
(2.04–2.55). It is important to note that the baseline risk for women
is higher as MDD is more prevalent in women; therefore, equiva-
lent IRRs will lead to a larger number of cases in women than
in men.
For disorders for which there were sufficient number of cases to
separate into categories according to how recently relative to the
onset of depression the sleep disorder was treated, we evaluated
the IRRs according to time since onset. Both inorganic and organic
insomnia and hypersomnia were pooled together for this analysis.
The results are presented in Table 3.
A general trend of decreasing risk for depression as the time
since being diagnosed with a sleep disorder was found. For insom-
nia, there was a large decrease in risk after the first 6 months since
diagnosis. However, even 12 months postdiagnosis, there was still
at least a two-fold increased risk of incident depression.
Discussion
The relationship between sleep disorders and depression is an
important area of research owing to the growing evidence that
sleep problems can precede onset of psychiatric disorders. Sleep
disorders are potentially critical modifiable risk factors for psychi-
atric disorders. If sleep problems are promptly treated, they can
relieve symptoms of depression and potentially prevent develop-
ment of a depressive disorder. A number of studies have attempted
to estimate the increased risk to depression attributable to sleep
disorders. The present study leverages population medical records
to investigate the relationship and has several advantages attribut-
able to using population medical records: inclusion of large
numbers of individuals across a wide age range, avoidance of biases
related to ascertainment and loss to follow-up, and no reliance on
self-report information.
This is to our knowledge the first study of the longitudinal risk
associated with sleep disorders in an entire population. Nearly all
incident cases of depression diagnosed at a hospital in Denmark
from 1995 to 2013 were included. The risk ratios between disorders
can be directly compared. There is little loss to follow-up and each
person can be followed for a long time after being diagnosed with a
sleep disorder. There are also several limitations to this study that
need to be considered and that might affect generalizability to
other populations and these are discussed below.
Depression and Sleep Disorders
We found that there was an increased risk of incident depression in
cases for all sleep disorders analyzed. Even without knowing the
specific disorder, a patient presenting with any sleep disorder is
at approximately 2.33-fold greater risk of later diagnosis of
MDD. Due to limitations of the sample size and privacy concerns
associated with register-based data, in most cases it was not
possible to evaluate risk to depression associated with specific
diagnoses, and instead disorders were grouped by broad diagnostic
categories.
Insomnia
It is perhaps not surprising that one of the highest IRRs was found
for insomnia, and specifically insomnia of nonorganic origin. A
pathway from insomnia to depression was first established by
Ford and Kamerow (1989), and since then there have been more
than 40 studies evaluating the risk for depression associated with
insomnia (Baglioni et al., 2011). A metaanalysis of 21 studies that
evaluated risk of developing depression in insomnia patients gave
an estimated odds ratio of 2.6 in a random-effects model.
In the present study, we estimate the IRR for inorganic insom-
nia as 6.76 (adjusted 5.80) and for insomnia of any kind 5.47
(adjusted 4.72). This estimate is higher than all of the studies
included in the metaanalysis apart from the study by Perlis et al.
(2006), which was conducted in elderly patients.
One possible reason why the estimated IRR is higher in this
study may be due to the fact that data recorded in registers may
include only very severe forms of insomnia and also severe forms
of depression (general practice health records are not available).
Support for this comes from the fact that the prevalences of sleep
disorders are low compared to those found in other studies.
Table 3. IRRs by time since diagnosis for a sleep disorder
Disorder <6 months prior 6–12 months prior More than 12 months prior
Insomnia 11.60 (5.84–23.05) 3.53 (1.03–12.04) 3.78 (2.42–5.90)
Hypersomnia 4.11 (1.92–8.79) 3.45 (1.34–8.91) 2.45 (1.78–3.76)
All inorganic sleep disorders 10.69 (4.98–22.95) 2.61 (0.78–8.69) 3.26 (2.36–4.51)
OSA 4.46 (2.38–8.33) 3.88 (1.97–7.64) 3.18 (2.03–4.99)
Any organic sleep disorder 2.71 (2.04–3.60) 2.83 (2.10–3.80) 2.30 (2.07–2.56)
Any sleep disorder 3.10 (2.38–4.01) 2.83 (2.12–3.77) 2.36 (2.14–2.62)
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The prevalence of insomnia in depression cases was only 0.04%.
This is substantially lower than the estimated prevalence of insom-
nia of 10–15% found in other studies, and in some instances, the
prevalence of insomnia has been found to be greater than 50% in
patients with depression.
Hypersomnia and Narcolepsy
The estimated IRR of hypersomnia was approximately half that of
insomnia, indicating that excessive sleep is not as strong a risk fac-
tor for developing depression as insufficient sleep. The even lower
IRR of narcolepsy (2.00) supports this, although narcolepsy may
have different biological underpinnings than other forms of hyper-
somnia, making the comparison complicated.
Hypersomnia is endorsed as a symptom of depression at a
much lower rate than insomnia, but daytime fatigue is common.
There are few longitudinal studies of the relationship between
hypersomnia and depression. Ford and Kamerow found higher
rates of incident depression in those with hypersomnia compared
to insomnia based on survey data (Ford & Kamerow, 1989).
Another study by Breslau et al. (1996) found a lower odds ratio
of incident depression in hypersomnia compared to insomnia, a
similar finding to the present study. Likewise, in a cross-sectional
study of patients with sleep disorders, Vandeputte and de Weerd
(2003) found that the rate of depression in hypersomnia patients
was half that in insomnia patients. These differences between
studies may reflect heterogeneity in assessment of hypersomnia,
with some being based on self-report and others including cases
diagnosed by a physician.
Cross-sectional studies of narcolepsy and depression have
found increased rates of depressive symptoms in narcolepsy with
cataplexy patients (Krishnan et al., 1984; Roy, 1976). But an
increase in the rates of depressive disorder has not been detected
(Fortuyn et al., 2010; Vourdas et al., 2002). After adjusting for con-
founders, the IRR in narcolepsy patients was 1.27, not significantly
different to 1. While not ruling narcolepsy out as a risk factor for
depression, these results support the hypothesis that the risk is
lower than for other sleep disorders.
Circadian Rhythm Disorders
Disruptions to circadian rhythms in depression have been well
documented, and patients with circadian disorders have elevated
rates of depression (Germain & Kupfer, 2008). To our knowledge,
this is the first study to investigate the longitudinal relationship
between circadian disruption and depression. Although limited
by small sample size, our results indicate that circadian rhythm dis-
orders are strong risk factors for developing MDD. Further inves-
tigation is required to understand how this risk is mediated. It is
possible that insomnia brought about by an underlying circadian
disruption could lead to increased risk of depression. More studies
with larger sample sizes are needed. We were unable to investigate
the relationship between specific circadian disorders and depres-
sion due to insufficient sample size.
Parasomnias and Sleep Movement Disorders
Parasomnias, including night terrors and nightmare disorder,
remain understudied compared to other sleep disorders.
Depressive symptoms are common in people with parasomnias
(Beauchemin & Hays, 1996; Kales et al., 1980; Llorente et al.,
1992), but there have been no studies evaluating the risk of incident
depression in those who suffer from them. One possible reason for
this is that patients rarely present with a parasomnia without
depression. We estimate the adjusted IRR of MDD in those with
a parasomnia to be 2.66. This is lower than the IRR for insomnia,
suggesting that periodic disruptions to sleep are not as harmful as
persistent lack of sleep.
Sleep movement disorders are a broad category of disorder cov-
ering periodic leg movement disorder, leg cramps and bruxism. As
yet, few studies have evaluated risk of developing depression in
sleep-related movement disorders. Our findings suggest those with
a movement disorder are at three-fold greater risk of developing
depression and screening for depression may be warranted.
Interestingly, the relative risk for women was twice as large as
for men. Further studies are needed to understand why women
are at increased risk.
OSA and Sleep-Disordered Breathing (SDB)
OSA is one of the most common sleep disorders and is the most
common single sleep disorder found in the Danish registers.
Prevalence studies have found a wide range of rates of self-report
depression in OSA patients (7–60%; Harris et al., 2009; Saunamaki
& Jehkonen, 2007). Correlational studies of OSA severity and
scores on depression scales have had mixed results, with some
studies showing a more consistent relationship in women
(Harris et al., 2009). One longitudinal study found increased risk
of developing depression with increasing OSA severity (Peppard
et al., 2006).
In the present study, we found that OSA is a risk factor for
MDD (adjusted IRR= 3.58). Due to the high prevalence of OSA
and SDB, we were able to separately evaluate the risk of OSA
and other breathing disorders. We found that OSA is a stronger
risk factor for depression than other types of SDB (adjusted IRR
3.58 compared to 1.98). Our results suggest that breathing difficul-
ties caused by obstruction of the airways confer greater risk to
developing depression.
Inorganic Versus Organic Sleep Disorders
The risk for depression was significantly higher for inorganic dis-
orders (adjusted IRR= 4.09, 95% confidence interval (CI) [3.14,
5.33]) than for organic disorders (adjusted IRR = 2.20, 95%CI
[2.01, 2.41]). This is perhaps not surprising given that inorganic
disorders are those where there is a mental rather than physical
origin. This may reflect real differences in risk because of shared
etiology, but it could also reflect differences in treatment and care,
whereby patients diagnosed with an inorganic disorder are more
likely to be referred for a psychiatric evaluation.
Interval Between Sleep Disorders and Development of
Depression
Further analyses showed that the risk of developing depression is
highest in those recently diagnosed with a sleep disorder. But those
who do not develop depression in the year subsequent to develop-
ing a sleep disorder remain at risk. It is therefore important to
monitor patients with sleep disorders even years after they were
diagnosed in order to try to minimize the risk of developing
depression. The increased risk that remains may be specific to
those whose sleep disorder is refractory to treatment or who suffer
a relapse. It was not possible to test such a hypothesis in the present
study. The results of these analyses should be interpreted with cau-
tion because they represent the time that a person presented to a
hospital and received a diagnosis. The symptoms may have started
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some time prior to the time of diagnosis and may have required a
person to reach a threshold of symptom severity before seeking
help from a general or psychiatric hospital. In addition, patients
diagnosed with a sleep disorder may have been monitored for a
period of time by doctors for depression, thus increasing the like-
lihood that they would receive a diagnosis soon after diagnosis with
a sleep disorder.
Prevalence of Sleep Disorders in Danish Registers
While there are myriad advantages of using register data, one limi-
tation of the study is that the prevalences of sleep disorders in the
registers are much lower than those found in other studies. This
limitation means that it was not possible to investigate the risk
associated with each specific sleep disorder diagnosis. Data from
the health registers come only from general and psychiatric hospi-
tals. General practitioners (GPs) represent the first line of care in
Denmark, and it is by referral from a GP that a patient goes to the
hospital. For individuals suffering with a sleep disorder, it is likely
that they will first seek advice from a GP, whomay suggest a course
of treatment such as pharmaceutical intervention in the case of
insomnia or narcolepsy.
Likewise, for those suffering from depression, a GP may pre-
scribe antidepressants or another therapy that helps to manage
the condition. Only in instances where there is significant worsen-
ing in symptoms might someone be referred to a hospital for treat-
ment as an inpatient or outpatient. Information on diagnoses given
by GPs is not available in the registers and is a significant limitation
of this study. A previous evaluation of the prevalence of depression
in sleep disorder patients found that while the overall prevalence of
depression as measured by a score of >10 on the Beck Depression
Scale was high (e.g., 60.5% for insomnia and 41% for OSA), the rate
of moderate–severe depression was much lower (1.4% for insom-
nia and 1.6% for OSA; Vandeputte & de Weerd, 2003).
There may be other reasons as to why the prevalence rates of
sleep disorders are low compared to estimates in other populations.
One possible explanation is that there is not enough recognition of
sleep disorders as distinct disorders in Denmark, and that in most
cases, sleep complaints are considered secondary to a primary
diagnosis of a psychiatric disorder. The sleep disorder cases found
here may present without any psychiatric symptoms.
Conclusions
Using data from Danish population registers, we show that all cat-
egories of sleep disorder are risk factors for incident MDD.
Insomnia and circadian rhythm disorders have the highest associ-
ated risk, while narcolepsy and SDB disorders excluding OSA have
the lowest associated risk. We found differences in risk between
men and women for insomnia, OSA and sleep movement disor-
ders. Furthermore, we found that there is a moderate decrease
in risk of depression as the time since diagnosis of a sleep disorder
decreases, but that most cases of depression were diagnosed more
than a year after diagnosis of a sleep problem. Our results have
implications for clinical practice. Depression screening should
be considered for patients with sleep disorders, and where possible,
long-term follow-up for mental health problems is advisable.
Differences in risks between genders should also be considered
in clinical practice.
Supplementary material. To view supplementary material for this article,
please visit https://doi.org/10.1017/thg.2019.22.
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